WFS1

Wolframin · O76024 · WFS1 on Sugi Atlas →

0 patent compounds predicted against WFS1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to WFS1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome PHASE2UNKNOWN
Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss PHASE1/PHASE2COMPLETED
Looking for VUS to Confirm Dominant Wolfram-like Syndrome Instead of Recessive Wolfram Syndrome nanACTIVE_NOT_RECRUITING
I-Tracking Neurodegeneration in Early Wolfram Syndrome nanCOMPLETED
Tracking Neurodegeneration in Early Wolfram Syndrome nanCOMPLETED
Does Recessive Optic Atrophy Due to WFS1 Exist? nanNOT_YET_RECRUITING
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study nanRECRUITING
Genomic Medicine for Ill Neonates and Infants (The GEMINI Study) nanCOMPLETED
Evaluation of the Effects of KCNQ1 Mutation on Insulin Tolerance and Obsessive Compulsive Features in Long QT Romano-Ward Syndrome Patients. nanUNKNOWN
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions nanCOMPLETED
Genetic Analyses of Nonsyndromic and Syndromic Deafness in Pakistan nanENROLLING_BY_INVITATION
Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank nanCOMPLETED
Mutation Exploration in Non-acquired, Genetic Disorders and Its Impact on Health Economy and Life Quality nanCOMPLETED
Defining the Brain Phenotype of Children With Williams Syndrome nanRECRUITING
Development and Clinical Application of Two New Genetic Deafness Gene Diagnostic Kit nanUNKNOWN
Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets nanRECRUITING
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis nanWITHDRAWN
Clinical Utility of Pediatric Whole Exome Sequencing nanCOMPLETED
Impact of Elastin Mediated Vascular Stiffness on End Organs nanCOMPLETED
Genetic Analysis of Fraser Syndrome and Fryns Syndrome nanCOMPLETED
Rapid Whole Genome Sequencing Study nanENROLLING_BY_INVITATION
Long-term Renal Prognosis of Neonatal Acute Kidney Injury nanNOT_YET_RECRUITING
Clinical Utility of Prenatal Whole Exome Sequencing nanCOMPLETED
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
Uncovering the Etiologies of Non-immune Hydrops Fetalis nanENROLLING_BY_INVITATION
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Genomic Profiling of Genetic and Rare Diseases nanRECRUITING
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a WFS1 binder may also engage these)

ProteinNameSimilarity
P56695 1.000 P56695 →
O88480 0.993 O88480 →
Q6DF19 0.993 Q6DF19 →
Q4VBG5 0.993 Q4VBG5 →
Q5ZLS8 0.991 Q5ZLS8 →
Q91ZD4 0.991 Q91ZD4 →
Q8TAA9 0.990 Q8TAA9 →
Q66H44 0.990 Q66H44 →
Q3UHQ6 0.990 Q3UHQ6 →
B4N5D3 0.990 B4N5D3 →
Q91VB4 0.990 Q91VB4 →
B4J2W3 0.989 B4J2W3 →
A1A4J7 0.989 A1A4J7 →
Q96HH4 0.989 Q96HH4 →
B4LC58 0.988 B4LC58 →
PIK3C2B Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta 0.988 landscape →
Q62141 0.988 Q62141 →
Q99K74 0.988 Q99K74 →
Q6NRB7 0.988 Q6NRB7 →
Q9P2D8 0.988 Q9P2D8 →
Q6AX31 0.988 Q6AX31 →
Q91YN0 0.988 Q91YN0 →
F1QN74 0.988 F1QN74 →
Q9WU61 0.988 Q9WU61 →
B4PF15 0.988 B4PF15 →
Q8R4Z9 0.988 Q8R4Z9 →
BRI3BP BRI3-binding protein 0.988 landscape →
Q5F3M0 0.988 Q5F3M0 →
A2BID5 0.988 A2BID5 →
Q99ML0 0.988 Q99ML0 →